Tandem Diabetes Care

Tandem Diabetes Care is honored to be recognized by TIME as one of the World’s Top HealthTech Companies of 2025 in the Medical Devices & Wearables category! Learn more at https://lnkd.in/geZfre8A.

Tandem Diabetes Care has achieved ISO/IEC 27001:2022 Certification from Insight Assurance, affirming Tandem’s company-wide commitment to cybersecurity, data protection, and operational integrity. As Tandem continues to expand internationally, the ISO/IEC 27001:2022 certification strengthens its position in regulated markets and simplifies compliance for partners and healthcare providers worldwide. Read more at: https://lnkd.in/gvdvdF5c. Individual symptoms, situations, circumstances, and results may vary. Important Safety Information: RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older and for patients with type 2 diabetes, 18 years and older. BOXED WARNING: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds, as those are the required minimum values needed for Control-IQ+ to operate safely.Safety info: https://lnkd.in/d3SmUSb.

The t:slim X2 insulin pump now integrates with the FreeStyle Libre 3 Plus sensor, the world’s smallest continuous glucose monitor*(1). The t:slim X2 insulin pump is powered by Control-IQ+ technology, so users can now experience better overall glucose control with proven accuracy (2) for up to 15 days in adult and pediatric patients. Visit https://lnkd.in/gsZ2R65V to learn more about this new sensor integration and how in-warranty t:slim X2 pump users in the United States can update today! *Among patient-applied sensors 1. Data on file. Abbott Diabetes Care. 2. FreeStyle Libre 3 Plus User’s Manual Individual symptoms, situations, circumstances, and results may vary. Important Safety Information: RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older and for patients with type 2 diabetes, 18 years and older. BOXED WARNING: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds, as those are the required minimum values needed for Control-IQ+ to operate safely. Safety info: https://lnkd.in/d3SmUSb. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission. For full FreeStyle Libre 3 Plus sensor safety information, please visit https://lnkd.in/gSnHCjvp.

Tandem Diabetes Care is excited to be a part of #GHC25, the world’s largest gathering of women in tech, which brings together thousands of women from across the globe to learn, network, and celebrate their achievements. Founded in 1994 by Dr. Anita Borg and Dr. Telle Whitney, GHC was created to honor the legacy of computing pioneer Grace Hopper and to amplify the research, career growth, and impact of women in tech. Swing by our booth in the Talent Expo to explore career opportunities and network with our team. See you there! #GraceHopperCelebration2025 #AnitaBorg

Diabetes leaders are raising their voices for fair and equitable access to insulin pumps. In “Home Medical Equipment News”, Chris Dawson from Tandem shares insights on why Medicare reform matters — not just for people with diabetes, but for the future of innovation and care. The Centers for Medicare & Medicaid Services (CMS) is reviewing diabetes policy right now. Your lived experience is the voice they need to hear. Contact your state representative today and help secure the change people with diabetes deserve. Read more at https://lnkd.in/gXJgseyw.

It’s almost here! The t:slim X2 insulin pump integration with the FreeStyle Libre 3 Plus sensor, the world’s smallest continuous glucose monitor*(1) is coming soon. Visit https://lnkd.in/gGr9zPA9 to stay up to date on this exciting new CGM integration! *Among patient-applied sensors 1. Data on file. Abbott Diabetes Care. Individual symptoms, situations, circumstances, and results may vary. Important Safety Information: RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older and for patients with type 2 diabetes, 18 years and older. BOXED WARNING: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds, as those are the required minimum values needed for Control-IQ+ to operate safely. Safety info: https://lnkd.in/d3SmUSb. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission. For full FreeStyle Libre 3 Plus sensor safety information, please visit https://lnkd.in/gSnHCjvp.

Lyumjev is now compatible with the t:slim X2 insulin pump with Control-IQ+ technology in the United States. Lyumjev is a fast-acting insulin with the same active ingredient as Humalog, but it's designed to help insulin be absorbed into the body quickly. ¹ To learn more about this integration, please see our press release: http://spklr.io/6047BJd1S ¹ Lyumjev: A fast-acting mealtime insulin. (n.d.). Lyumjev. Retrieved June 26, 2025, from http://spklr.io/6048BJd1s Individual symptoms, situations, circumstances, and results may vary. Important Safety Information: RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older and for patients with type 2 diabetes, 18 years and older. BOXED WARNING: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds, as those are the required minimum values needed for Control-IQ+ to operate safely. Safety info: http://spklr.io/6049BJd1t.

The Tandem Diabetes Care team had a fantastic time attending the National Sales Network (NSN) Professional Conference earlier this month! It was a great opportunity to share who we are, what we stand for, and the exciting career opportunities at Tandem. Special thanks to everyone who stopped by our booth during the career fair. We enjoyed every conversation and look forward to staying in touch! #NSN2025

Tandem Diabetes Care offers two unique AID systems, both powered by Control-IQ+ technology, that give your patients the options they need to best fit their lifestyle. Tandem Mobi is the world’s smallest, durable AID system (1). It’s the tiny pump that’s big on control. The t:slim X2 insulin pump is the user-friendly, all-in-one system that has an intuitive color touchscreen. Learn more: https://lnkd.in/g8KbF56H #ADCES2025 #TandemDiabetesCare Adhesive sleeve sold separately. *The mobile app requires a compatible iPhone model and operating system (sold separately). Only available to pump users who reside in the United States. 1. As of Aug., 2025. Data on file, Tandem Diabetes Care Important Safety Information: RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older and for patients with type 2 diabetes, 18 years and older. BOXED WARNING: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds, as those are the required minimum values needed for Control-IQ+ to operate safely. Safety info: https://lnkd.in/d3SmUSb.